Similarly, IL-10 transgene supplementation was successful in IL10-/- mice, as evidenced by the serum IL-10 level, and significantly reduced index scores of enterocolitis activity, increased weight-to-length colonic ratios, and decreased scores of microscopic inflammation52. The gene discussed is IL10; the disease is enterocolitis.